Zeleke Tirsit Kestela, Birhan Tilahun Yemanu, Abdela Ousman Abubeker
Department of Pharmacy, College of Medicine and Health Sciences, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia.
Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine & Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia.
Int J Nephrol. 2021 Dec 1;2021:8238250. doi: 10.1155/2021/8238250. eCollection 2021.
Kidney disease affects absorption, distribution, metabolism, and excretion of medicines and their metabolites. Therefore, when prescribing medicines for patients with kidney disease, dose adjustment is an accepted standard of practice.
This study aimed to assess medicine dose adjustment practice and associated factors among adult patients with renal impairment admitted to medical wards at Amhara region referral hospitals.
Multicenter, institution-based, cross-sectional study was conducted from March 28, 2020, to August 30, 2020. The data was collected by using a pretested interviewer-administered structured questionnaire. Data were entered into Epi-Data version 4.6 and transferred into SPSS version 25 for further data processing and analysis. Descriptive statistics such as frequencies and percentages were computed. Both bivariable and multivariable binary logistic regression analyses were fitted to identify factors associated with dose adjustment practice. A 95% confidence interval and a value less than 0.05 were used to declare statistical significance.
Among 815 medicines' prescriptions that needed dose adjustment, 417 (51.2%) of them were dosed inappropriately. Number of medicines, number of comorbidities, and being unemployed were significantly associated with inappropriate dose adjustment.
Our study revealed that there was a considerable rate of inappropriate dose adjustment in patients with renal impairment. Training for health care providers, use of guidelines, and communication with clinical pharmacists should be encouraged for good prescription practice.
肾脏疾病会影响药物及其代谢产物的吸收、分布、代谢和排泄。因此,为肾病患者开药时,调整剂量是公认的标准做法。
本研究旨在评估阿姆哈拉地区转诊医院内科病房收治的成年肾功能损害患者的药物剂量调整情况及相关因素。
于2020年3月28日至2020年8月30日进行了一项多中心、基于机构的横断面研究。数据通过预先测试的访谈员管理的结构化问卷收集。数据录入Epi-Data 4.6版本,并转入SPSS 25版本进行进一步的数据处理和分析。计算频率和百分比等描述性统计数据。采用双变量和多变量二元逻辑回归分析来确定与剂量调整做法相关的因素。使用95%置信区间和小于0.05的P值来宣布具有统计学意义。
在815张需要调整剂量的药物处方中,有417张(51.2%)剂量调整不当。药物数量、合并症数量和失业与剂量调整不当显著相关。
我们的研究表明,肾功能损害患者中存在相当比例的剂量调整不当情况。应鼓励对医护人员进行培训、使用指南并与临床药剂师沟通,以实现良好的处方实践。